Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, ICT and Future Planning (RS-2023-00209828)
- National Research Foundation of Korea
- Konkuk University - Seoul Campus
This publication has 49 references indexed in Scilit:
- Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickensVaccine, 2023
- Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducksVaccine, 2022
- Global production capacity of seasonal and pandemic influenza vaccines in 2019Vaccine, 2021
- Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickensVaccine, 2018
- Emergence and dissemination of clade 2.3.4.4 H5Nx influenza viruses — how is the Asian HPAI H5 lineage maintainedCurrent Opinion in Virology, 2016
- Avian Influenza Virus Isolation, Propagation, and Titration in Embryonated Chicken Eggs2014
- Immune responses of poultry to Newcastle disease virusDevelopmental & Comparative Immunology, 2013
- Success Factors for Avian Influenza Vaccine Use in Poultry and Potential Impact at the Wild Bird–Agricultural InterfaceEcohealth, 2013
- Emergence of multiple clade 2.3.2.1 influenza A (H5N1) virus subgroups in Vietnam and detection of novel reassortantsVirology, 2013
- Immunoglobulin genetics and antibody responses to influenza in ducksDevelopmental & Comparative Immunology, 2011